Participate in polls relating to real-time continuous glucose monitoring and see how your answers relate to your colleagues.

A study to evaluate the safety and effectiveness of the Omnipod 5 System over 12 months of use in children with T1D aged 2 to <6 demonstrated 49% achieved HbA1c of <7.0% compared with 31% at baseline.
a. True
b. False

Submit is supported by independent educational grants from Ascensia Diabetes Care, Insulet Corporation, Madrigal Pharmaceuticals and Stanford University.
©2023 CogniMed Inc. All rights reserved.